Third Molar Extraction Completed Phase 4 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0035848 (Third Molar Extraction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01541059Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus PlaceboTreatment